Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam · Delayed Price · Currency is VND 8,000.00
+100.00 (1.27%)
At close: Aug 12, 2026
HNX:LDP Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 28,079 | 28,558 | 6,919 | -20,105 | -38,891 | 37,870 |
Depreciation & Amortization | 4,850 | 5,655 | 6,964 | 8,237 | 8,900 | 11,742 |
Other Amortization | 68.6 | 68.6 | - | - | - | - |
Loss (Gain) From Sale of Assets | -14,394 | -14,394 | -345.18 | 140.99 | 7,710 | -32,237 |
Other Operating Activities | 11,410 | 3,445 | 4,784 | 6,163 | 15,222 | 2,037 |
Change in Accounts Receivable | -15,960 | -18,617 | -8,905 | -2,572 | -49,880 | 12,794 |
Change in Inventory | -19,679 | -6,460 | -11,211 | 18,201 | -1,344 | 21,579 |
Change in Accounts Payable | 12,498 | 3,701 | 13,960 | -9,415 | 24,385 | -24,597 |
Change in Other Net Operating Assets | 431.73 | -1,076 | -1,371 | 5,355 | -4,627 | -110.66 |
Operating Cash Flow | 4,195 | 3,452 | 8,766 | 6,036 | -44,803 | 29,077 |
Operating Cash Flow Growth | 2403.68% | -60.62% | 45.23% | - | - | 73.46% |
Capital Expenditures | -62,677 | -63,046 | -2,930 | -59.05 | -1,916 | -7,685 |
Sale of Property, Plant & Equipment | - | - | 63.64 | - | - | 41,371 |
Other Investing Activities | 489.94 | 355.34 | 281.55 | 538.64 | 1,391 | 230.03 |
Investing Cash Flow | -62,187 | -62,691 | -2,585 | -1,520 | -15,798 | 33,916 |
Short-Term Debt Issued | - | 143,227 | 118,842 | - | - | - |
Long-Term Debt Issued | - | - | - | 117,632 | 181,261 | 77,271 |
Total Debt Issued | 152,720 | 143,227 | 118,842 | 117,632 | 181,261 | 77,271 |
Short-Term Debt Repaid | - | -141,279 | -129,775 | - | - | - |
Long-Term Debt Repaid | - | - | - | -122,561 | -169,202 | -94,268 |
Total Debt Repaid | -152,653 | -141,279 | -129,775 | -122,561 | -169,202 | -94,268 |
Net Debt Issued (Repaid) | 66.65 | 1,948 | -10,934 | -4,929 | 12,059 | -16,997 |
Issuance of Common Stock | 58,103 | 64,453 | - | - | - | - |
Financing Cash Flow | 58,170 | 66,401 | -10,934 | -4,929 | 12,059 | -16,997 |
Foreign Exchange Rate Adjustments | - | - | - | - | 2.01 | - |
Net Cash Flow | 177.8 | 7,163 | -4,753 | -413.65 | -48,540 | 45,996 |
Free Cash Flow | -58,482 | -59,594 | 5,835 | 5,977 | -46,718 | 21,392 |
Free Cash Flow Growth | - | - | -2.37% | - | - | 1789.48% |
Free Cash Flow Margin | -22.32% | -24.43% | 2.68% | 3.21% | -24.93% | 13.21% |
Free Cash Flow Per Share | -3486.87 | -4235.81 | 459.36 | 470.51 | -3678.26 | 1683.88 |
Levered Free Cash Flow | -124,468 | -132,671 | 5,767 | 8,319 | -60,243 | - |
Unlevered Free Cash Flow | -118,233 | -130,071 | 8,878 | 12,710 | -55,528 | - |
Cash Interest Paid | 2,875 | 2,058 | 1,929 | 5,413 | 7,544 | 2,105 |
Cash Income Tax Paid | - | - | - | - | -3,342 | - |
Change in Working Capital | -25,819 | -19,881 | -9,556 | 11,600 | -37,744 | 9,665 |